Jennifer Lynn Minai-Azary insider trades: Context Therapeutics (CNTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jennifer reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | CNTX | ↑ Buy | 40,010 | $0.64 | $25K | Direct | Jun 10, 2025 (4d) |
| Dec 16, 2022 | CNTX | ↑ Buy | 25,000 | $0.74 | $19K | Direct | Dec 19, 2022 (3d) |
| Aug 17, 2022 | CNTX | ↑ Buy | 15,000 | $1.80 | $27K | Direct | Aug 17, 2022 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jennifer Lynn Minai-Azary's insider trades
Jennifer Lynn Minai-Azary is Chief Financial Officer at Context Therapeutics (CNTX). Since Aug 17, 2022, Jennifer has reported 3 open-market purchases worth $71K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.